Impact of undernutrition on the pharmacokinetics of chemotherapy in children with cancer: A systematic review

Objectives This systematic review provides an overview of the effect of undernutrition on the pharmacokinetics of chemotherapy in children with cancer. Methods PubMed, Embase, and Cochrane were searched to identify eligible studies. This study uses the definition for undernutrition from the World He...

Full description

Saved in:
Bibliographic Details
Published in:Pediatric blood & cancer 2023-09, Vol.70 (9), p.e30531-n/a
Main Authors: Schoon, Sterre, Makamo, Nthongase, Uittenboogaard, Aniek, Bernhardt, Melanie B., Ozuah, Nmazuo W., Kaspers, Gertjan J. L., Huibers, Minke H. W.
Format: Article
Language:English
Subjects:
Cancer
Chemotherapy
Children
Hematology
Nutritional status
Oncology
pediatric oncology
Pediatrics
Pharmacokinetics
Systematic review
Undernutrition
Vincristine
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Objectives This systematic review provides an overview of the effect of undernutrition on the pharmacokinetics of chemotherapy in children with cancer. Methods PubMed, Embase, and Cochrane were searched to identify eligible studies. This study uses the definition for undernutrition from the World Health Organization and the Gomez classification. Results Four studies with a total of 668 children with cancer were included and n = 121 (18%) were undernourished. Significant decreased clearance rates were found for vincristine in undernourished children compared to children with a normal nutritional status. Conclusion Presenting outcomes only show significant changes in the pharmacokinetics of vincristine in undernourished children with cancer. However, data are scarce, groups were small, and none of the studies included severely undernourished children. In order to improve outcomes for (severely) undernourished children with cancer, more pharmacokinetic research is needed. The ultimate goal would be to develop subgroups, and ultimately individualized drug dosing in order to improve outcomes for children with cancer worldwide.
ISSN:1545-5009
1545-5017
DOI:10.1002/pbc.30531